Predicting post-liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning

Am J Transplant. 2023 Dec;23(12):1908-1921. doi: 10.1016/j.ajt.2023.08.022. Epub 2023 Aug 30.

Abstract

Liver transplantation (LT) is a treatment for acute-on-chronic liver failure (ACLF), but high post-LT mortality has been reported. Existing post-LT models in ACLF have been limited. We developed an Expert-Augmented Machine Learning (EAML) model to predict post-LT outcomes. We identified ACLF patients who underwent LT in the University of California Health Data Warehouse. We applied the RuleFit machine learning (ML) algorithm to extract rules from decision trees and create intermediate models. We asked human experts to rate the rules generated by RuleFit and incorporated these ratings to generate final EAML models. We identified 1384 ACLF patients. For death at 1 year, areas under the receiver-operating characteristic curve were 0.707 (confidence interval [CI] 0.625-0.793) for EAML and 0.719 (CI 0.640-0.800) for RuleFit. For death at 90 days, areas under the receiver-operating characteristic curve were 0.678 (CI 0.581-0.776) for EAML and 0.707 (CI 0.615-0.800) for RuleFit. In pairwise comparisons, both EAML and RuleFit models outperformed cross-sectional models. Significant discrepancies between experts and ML occurred in rankings of biomarkers used in clinical practice. EAML may serve as a method for ML-guided hypothesis generation in further ACLF research.

Keywords: ACLF; UCHDW; big data; machine learning; posttransplant outcomes.

MeSH terms

  • Acute-On-Chronic Liver Failure* / etiology
  • Acute-On-Chronic Liver Failure* / surgery
  • Biomarkers
  • Cross-Sectional Studies
  • Humans
  • Liver Transplantation* / adverse effects
  • Prognosis
  • ROC Curve
  • Retrospective Studies

Substances

  • Biomarkers